Disclosures Under a license agreement between Corrie Health and the Johns Hopkins University, the University owns equity in Corrie Health and the University and Drs Marvel and Martin are entitled to royalty distributions related to the Corrie technology. Additionally, Drs Marvel and Martin are founders of and hold equity in Corrie Health. This arrangement has been reviewed and approved by the Johns Hopkins University in accordance with its conflict of interest policies. Dr Marvel has received material support from Apple and iHealth and has received funding from the Maryland Innovation Initiative, Wallace H. Coulter Translational Research Partnership, Louis B. Thalheimer Fund, PJ Schafer Cardiovascular Research Fund, the American Heart Association Empowered to Serve Business Accelerator, Kaneka and Amgen. Dr Martin has received material support from Apple and iHealth; has received funding from the Maryland Innovation Initiative, Wallace H. Coulter Translational Research Partnership, Louis B. Thalheimer Fund, the Johns Hopkins Individualized Health Initiative, the American Heart Association (20SFRN35380046, 20SFRN35490003, COVID19-811000, 878924, and 882415), the Patient-Centered Outcomes Research Institute (ME-2019C1-15 328 and IHS-2021C3-24147), the National Institutes of Health (P01 HL108800 and R01AG071032), the David and June Trone Family Foundation, the Pollin Digital Innovation Fund, the PJ Schafer Cardiovascular Research Fund, Sandra and Larry Small, Cascade Screening for Awareness and Detection FH, Google, Merck, and Amgen; and has received personal fees for consulting from Amgen, AstraZeneca, Bristol Myers Squibb, Chroma, Kaneka, NewAmsterdam, Novartis, Novo Nordisk, Sanofi, and 89bio. The other author reports no conflicts.